Sign In
Buy LLY
$1,231.58
+45.87 (+3.87%)
At Close: Aug 10, 2026
Time to Buy Eli Lilly (LLY) and AbbVie (ABBV) Stock for 2023?
09:49pm, Friday, 16'th Dec 2022
AbbVie's valuation, in particular, makes it a potentially strong candidate for 2023, while Eli Lilly's growth could support its stock next year.
JPMorgan's bullish call on biopharma
02:12pm, Friday, 16'th Dec 2022
The "Halftime Report" traders debate the biggest analyst calls of the day.
Pharma Stock Roundup: LLY's 2023 View, MRK-MRNA Joint Cancer Vaccine Data & More
01:07pm, Friday, 16'th Dec 2022 Zacks Investment Research
Eli Lilly (LLY) gives its financial guidance for 2023. Merck (MRK) and Moderna's (MRNA) mRNA-based cancer vaccine shows positive results in a joint study.
Tracking Stanley Druckenmiller's Duquesne Family Office Portfolio - Q3 2022 Update
09:40am, Friday, 16'th Dec 2022 Seeking Alpha
Stanley Druckenmiller’s 13F portfolio value increased from $1.38B to $1.76B this quarter. Read more to know Druckenmiller’s Q3 2022 portfolio update.
Lilly, Sosei to develop new treatments for diabetes and metabolic diseases
07:50am, Friday, 16'th Dec 2022
Eli Lilly & Co. Inc. and Sosei Group Corp. said Friday they plan to develop and commercialize therapies for diabetes and metabolic diseases. Lilly is paying the Japanese drug maker an upfront payment
2 Dividend Stocks That Could See Big Rate Increases Next Year
03:15pm, Thursday, 15'th Dec 2022 The Motley Fool
Both of these businesses are in good financial shape and can afford to boost their payouts significantly.
Carnival To Rally Over 36%? Here Are 10 Other Price Target Changes For Thursday
01:05pm, Thursday, 15'th Dec 2022 Benzinga
Barclays raised Carnival Corporation (NYSE: CCL) price target from $10 to $12. . Barclays analyst Brandt Montour maintained an Overweight rating on the stock. benzinga shares fell 1.6% to $8.79 in
SNY vs. LLY: Which Stock Is the Better Value Option?
04:40pm, Wednesday, 14'th Dec 2022 Zacks Investment Research
SNY vs. LLY: Which Stock Is the Better Value Option?
Eli Lilly (LLY) 2023 Guidance Falls Short, Stock Declines
04:39pm, Wednesday, 14'th Dec 2022 Zacks Investment Research
Eli Lilly's (LLY) 2023 EPS guidance falls short of the Zacks Consensus Estimates and our model estimates. The company plans to launch four new drugs next year.
Eli Lilly (LLY) 2023 Guidance Falls Short, Stock Declines
12:47pm, Wednesday, 14'th Dec 2022
Eli Lilly's (LLY) 2023 EPS guidance falls short of the Zacks Consensus Estimates and our model estimates. The company plans to launch four new drugs next year.
SNY vs. LLY: Which Stock Is the Better Value Option?
12:47pm, Wednesday, 14'th Dec 2022
SNY vs. LLY: Which Stock Is the Better Value Option?
Dow ends 100 points higher, stocks book back-to-back gains as Wall Street gauges cooler inflation report, awaits Fed rate decision
09:36pm, Tuesday, 13'th Dec 2022 MarketWatch
U.S. stock indexes end higher Tuesday, but off the session's best levels, as cooling consumer prices point to progress in the Federal Reserve's inflation fight.
Our Top 10 Stock Picks for 2023
02:53pm, Tuesday, 13'th Dec 2022
Before we discuss the top 10 stock picks for 2023, we can all agree that the economy has two pathways from here. One, the real impact of the rate hikes sits in front of us and will trigger a deep rece
The Bullish Call Eli Lilly Made For Its Next-Gen Obesity Drug, A Rival To Novo, Amgen
12:28pm, Tuesday, 13'th Dec 2022
Eli Lilly said Tuesday it plans to advance its next-generation obesity treatment into final-phase testing, but LLY stock dipped on guidance. The post The Bullish Call Eli Lilly Made For Its Next-Gen O
3 High-Flying Stocks to Buy and Hold If a Recession Is on the Way
10:57am, Tuesday, 13'th Dec 2022 The Motley Fool
An economic downturn shouldn't hurt these stocks.
